Who are Ovulation triggering with GnRH-a+rhCG's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ovulation-triggering-with-gnrh-a-rhcg.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Ovulation triggering with GnRH-a+rhCG — Competitive Intelligence Brief

Ovulation triggering with GnRH-a+rhCG (Ovulation triggering with GnRH-a+rhCG) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin. Area: Reproductive Medicine / Fertility.

marketed Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin GnRH receptor (for GnRH-a component); LH/hCG receptor (for rhCG component) Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Ovulation triggering with GnRH-a+rhCG (Ovulation triggering with GnRH-a+rhCG) — Fundación Santiago Dexeus Font. GnRH agonist priming followed by recombinant human chorionic gonadotropin (rhCG) triggers final oocyte maturation and ovulation in assisted reproductive technology cycles.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ovulation triggering with GnRH-a+rhCG TARGET	Ovulation triggering with GnRH-a+rhCG	Fundación Santiago Dexeus Font	marketed	Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin	GnRH receptor (for GnRH-a component); LH/hCG receptor (for rhCG component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin class)

Fundación Santiago Dexeus Font · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ovulation triggering with GnRH-a+rhCG — Competitive Intelligence Brief. https://druglandscape.com/ci/ovulation-triggering-with-gnrh-a-rhcg. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab